文献速递分子诊断临床微生物

Mucorales PCR快速诊断毛霉病:国家参考实验室与三级医院6年检测经验

Mucorales PCR for the rapid diagnosis of mucormycosis: 6 years of testing in a national reference laboratory and tertiary hospital.
PubMed 文献 · J Clin Microbiol · 2026-06-12

该研究回顾了6年间5779例Mucorales PCR和2017例真菌培养,评估PCR与培养、组织病理和泛真菌测序的一致性。PCR阳性率2.9%,窦道和其他新鲜组织标本诊断率最高(23.8%和19.4%),PCR较培养提前约7天出结果,特异性99%,假阴性主要来自血清和脑脊液。结论认为Mucorales PCR是疑似侵袭性霉菌病的有效辅助手段,应优先使用感染部位新鲜组织检测。

要点

  • Mucorales PCR报告比培养阳性提前约7天,有助于早期启动抗真菌治疗。
  • 窦道和其他新鲜组织标本PCR阳性率最高(23.8%和19.4%),应优先送检。
  • PCR特异性99%,假阴性主要见于血清和脑脊液标本。

核心结论

  • Mucorales PCR是疑似侵袭性霉菌病常规检测的有用辅助手段,周转时间较短且特异性高。

研究设计与样本

  • 回顾性分析6年间国家参考实验室和三级医院送检的5779例Mucorales PCR与2017例同患者真菌培养,并结合病历复核 adjudicate 疑似侵袭性霉菌病病例。

主要发现

  • PCR结果比Mucorales阳性培养约早7天发出。
  • 总体PCR阳性率为2.9%。
  • 窦道标本PCR阳性率23.8%,其他新鲜组织标本19.4%。
  • 培养阳性标本及组织标本的PCR循环阈值(Ct)显著更早,血清Ct最晚(所有比较P < 0.005)。
  • 在315例共享检测的标本中,PCR检出所有培养或测序阳性样本(n=13),方法间阴性符合率高达97.3%。

关键数值与推荐

  • PCR阳性率2.9%,窦道标本23.8%,其他新鲜组织19.4%。
  • PCR较培养提前约7天报告。
  • 培养阳性标本及组织标本Ct显著早于其他标本,血清Ct最晚(P < 0.005)。
  • 共享检测标本中阴性符合率97.3%,PCR特异性99%。
  • 确诊/临床诊断毛霉病中67%至少一次PCR阳性。

临床怎么用

  • 疑似侵袭性霉菌病时,Mucorales PCR可作为常规检测的快速辅助手段。
  • 尽可能采集感染部位的新鲜组织(如窦道标本)送检PCR。
  • 血清和脑脊液PCR阴性不能排除毛霉病,需结合组织检测。

局限性

  • 假阴性PCR见于血清(n=6)和脑脊液(n=1)标本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Mucormycosis is an invasive mold disease (IMD) caused by fungi in the order Mucorales. Early initiation of active antifungal therapy is critical for optimal outcomes, and molecular diagnostics can speed up the time to critical results. We reviewed 6 years of Mucorales polymerase chain reaction (PCR) testing to assess agreement with culture, histopathology, and/or pan-fungal sequencing across different specimen types. Medical record review was also performed to adjudicate cases of suspected IMD from our institution. A total of 5,779 PCRs and 2,017 fungal cultures from the same patients were performed during the study period. PCR results were issued approximately 7 days sooner than Mucorales-positive cultures. The overall PCR positivity rate was 2.9%. Sinus and other fresh tissue specimens had the highest diagnostic yield (23.8% and 19.4% PCR positive, respectively). PCR cycle thresholds (Cts) were significantly earlier for culture-positive specimens and for tissue versus other sample types, while serum had the latest Cts (all comparisons P < 0.005). Among 315 specimens with shared testing, PCR detected all culture- or sequencing-positive samples (n = 13), and negative percent agreement across methods was high (97.3%). Twenty-one cases of proven/probable mucormycosis were identified from our hospitals; 67% had at least one positive PCR. False-negative PCRs came from serum (n = 6) or cerebrospinal fluid (n = 1), while false positives were rare (PCR specificity: 99%). In conclusion, Mucorales PCR is a useful adjunct to routine testing for suspected IMD, given its relatively rapid turnaround time and high specificity. Testing should ideally be performed using fresh tissue from the primary site of infection when possible. IMPORTANCE: This work addresses a critical gap in the diagnosis of mucormycosis, a rapidly progressive and frequently fatal invasive mold disease for which timely, accurate laboratory confirmation is essential but often difficult to achieve. By evaluating over 6 years of real-world Mucorales polymerase chain reaction (PCR) testing in a national reference laboratory and tertiary-care setting, this study provides robust evidence that targeted PCR offers substantially faster turnaround times than culture while maintaining high specificity across multiple specimen types. The findings underscore the diagnostic value of molecular testing, particularly from fresh tissue obtained at the site of infection, and highlight important limitations of serum testing that can inform optimal test utilization. In the context of increasing mucormycosis incidence, absence of reliable antigen-based diagnostics, and the need for early antifungal therapy, these data support the incorporation of Mucorales PCR as a complementary tool to conventional methods.

来源:J Clin Microbiol,查看原文。版权归原作者所有。

引用

  1. Haas AL, Hanson KE. Mucorales PCR for the rapid diagnosis of mucormycosis: 6 years of testing in a national reference laboratory and tertiary hospital. J Clin Microbiol. 2026. PMID: 42284037. doi:10.1128/jcm.01911-25

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。